Effects of 1,2,4,6-tetra-O-galloyl-β-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2.2.15 cell culture

Virologica Sinica

Volumn 25, Issue 5, 2010, Pages 375-380

  Xiang, Yang Fei ^a   Ju, Huai Qiang ^a   Li, Shen ^a   Zhang, Ying Jun ^b   Yang, Chong Ren ^b   Wang, Yi Fei ^a  

^a JINAN UNIVERSITY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

1,2,4,6 tetra O galloyl D glucose (1246TGG); Antiviral agents; Euphorbiaceae; HBV; Phyllanthus emblica

Indexed keywords

1,2,4,6 TETRA O GALLOYL BETA DEXTRO GLUCOSE; CHINESE DRUG; EMBLICA OFFICINALIS EXTRACT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CHINESE MEDICINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; EMBLICA OFFICINALIS; ENZYME IMMUNOASSAY; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PHYTOCHEMISTRY;

ANTIVIRAL AGENTS; CELL LINE; GALLIC ACID; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; IMMUNOENZYME TECHNIQUES; MONOSACCHARIDES; PHYLLANTHUS EMBLICA; VIRUS REPLICATION;

EUPHORBIACEAE; HEPATITIS B VIRUS; PHYLLANTHUS EMBLICA; TETRA;

EID: 78249266942     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-010-3144-y     Document Type: Article

References (18)

1. D. Duan Z. Li H. Luo, et al. 2004 Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease Bioorg Med Chem Lett 20;14 24 6041 6044 10.1016/j.bmcl.2004.09.067 (Pubitemid 39531267)
2. S. EL-Mekkawy M. R. Meselhy I. T. Kusumoto, et al. 1995 Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase Chem Pharm Bull 43 4 641 648 1:CAS:528:DyaK2MXnsVWntbg%3D 7541317
3. K. Fukuchi H. Sakagami T. Okuda, et al. 1989 Inhibition of herpes simplex virus infection by tannins and related compounds Antiviral Res 11 5-6 285 297 1:CAS:528:DyaL1MXls1Krsbg%3D 10.1016/0166-3542(89)90038-7 2552915
4. B. E. Korba G. Milman 1991 A cell culture assay for compounds which inhibit hepatitis B virus replication Antiviral Res 15 3 217 228 1:CAS:528:DyaK3MXks1eru7c%3D 10.1016/0166-3542(91)90068-3 1716089
5. A. Lançon D. Delmas H. Osman, et al. 2004 Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process Biochem Biophys Res Commun 316 4 1132 1137 10.1016/j.bbrc.2004.02.164 15044102 (Pubitemid 38369070)
6. Lançon A, Hanet N, Jannin B, et al. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos, 35(5): 699-703.
7. W.M. Lee 1997 Hepatitis B virus infection N Engl J Med 337 24 1733 1745 1:STN:280:DyaK1c%2FktFyjtA%3D%3D 10.1056/NEJM199712113372406 9392700 (Pubitemid 27527771)
8. S. J. Lee H. K. Lee M. K. Jung, et al. 2006 In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose against hepatitis B virus Biol Pharm Bull 29 10 2131 2134 1:CAS:528:DC%2BD28XhtlSjurjO 10.1248/bpb.29.2131 17015965 (Pubitemid 44510823)
9. T. Manabu T. Masayuki T. Yasuo 1985 Studies on antiviral activity of several hydrolyzable tannins International congress series 667 223 224 (Herpes viruses virus chemother)
10. H. Nakashima K. Ichiyama F. Hirayama, et al. 1996 Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro, and reduces HIV infection in hu-PBL-SCID mice Antiviral Res 30 2-3 95 108 1:CAS:528:DyaK28XjtlSntbo%3D 10.1016/0166-3542(95)00903-5 8783802 (Pubitemid 26178130)
11. J. Sun J. L. Hou 2010 Management of chronic hepatitis B: experience from China J Viral Hepatitis 17 S1 10 17 10.1111/j.1365-2893.2010.01274.x
12. P. Tiollais C. Pourcel A. Dejean 1985 The hepatitis B virus Nature 317 5 489 495 1:CAS:528:DyaL2MXmtVOltLo%3D 10.1038/317489a0 2995835 (Pubitemid 16224154)
13. Q. Xia P. G. Xiao L. W. Wang, et al. 1997 Ethnopharmacology of Phyllanthus emblica L China J Chin Mat Med 22 9 515 518 1:STN:280: DC%2BD3cvovFSjtA%3D%3D
14. Y. F. Xiang Y. Pei Y. F. Wang 2008 Current status of natural products from plants as anti-herpes simplex virus 1 agents Virol Sin 23 5 305 314 1:CAS:528:DC%2BD1cXhtlemsLjL 10.1007/s12250-008-2962-7
15. S. J. Yeo Y. J. Yun M. A. Lyu, et al. 2002 Respiratory syncytial virus infection induces matrix metal-loproteinase-9 expression in epithelial cells Arch Virol 147 2 229 242 1:CAS:528:DC%2BD38Xkt1ensrc%3D 10.1007/s705-002-8316-1 11890521 (Pubitemid 34159546)
16. J. Zhang L. Li S. H. Kim, et al. 2009 Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose Pharm Res 26 9 2066 2080 1:CAS:528:DC%2BD1MXptlaku7w%3D 10.1007/s11095-009-9932-0 19575286
17. L. Zhang G. Wang W. Hou, et al. 2010 Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review Hepatology 51 2 690 698 20101751
18. Y. J. Zhang T. Abe T. Tanaka, et al. 2001 Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica J Nat Prod 64 12 1527 1532 1:CAS:528:DC%2BD3MXos1Whsr8%3D 10.1021/np010370g 11754604 (Pubitemid 34051972)